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Sterols and sphingolipids are limited to eukaryotic cells, and their interaction has been proposed to favor formation of
lipid microdomains. Although there is abundant biophysical evidence demonstrating their interaction in simple systems,
convincing evidence is lacking to show that they function together in cells. Using lipid analysis by mass spectrometry and
a genetic approach on mutants in sterol metabolism, we show that cells adjust their membrane composition in response
to mutant sterol structures preferentially by changing their sphingolipid composition. Systematic combination of
mutations in sterol biosynthesis with mutants in sphingolipid hydroxylation and head group turnover give a large
number of synthetic and suppression phenotypes. Our unbiased approach provides compelling evidence that sterols and
sphingolipids function together in cells. We were not able to correlate any cellular phenotype we measured with plasma
membrane fluidity as measured using fluorescence anisotropy. This questions whether the increase in liquid order phases
that can be induced by sterol–sphingolipid interactions plays an important role in cells. Our data revealing that cells have
a mechanism to sense the quality of their membrane sterol composition has led us to suggest that proteins might recognize
sterol–sphingolipid complexes and to hypothesize the coevolution of sterols and sphingolipids.
INTRODUCTION
Sterols are major plasma membrane components of most
eukaryotic membranes, although their precise structure dif-
fers between the kingdoms; animals contain cholesterol, and
plants have sitosterol, campesterol, and stigmasterol,
whereas fungi use mainly ergosterol. The plant and yeast
sterols both differ from cholesterol in their side chain, and
yeast sterols also have an extra double bond in the B ring. As
sterols appear only in eukaryotes, it is likely that they confer
properties to membranes or provide functions that may not
be required in prokaryotes and possibly not even in all
eukaryotes (Matyash et al., 2004). Cholesterol has been
shown to modulate membrane thickness in artificial mem-
branes, and this property has been proposed to play a role in
membrane protein localization in vivo (Bretscher and Mu-
nro, 1993) although an alternative explanation for the control
of membrane thickness has been postulated (Mitra et al.,
2004). Recently it has been shown that proteins and lipids do
not freely diffuse over the entire surface of the cell, and it has
been proposed that eukaryotic plasma membranes contain
micro/nanodomains (for review see Simons and Ikonen,
1997; Kusumi et al., 2005; Jacobson et al., 2007). Indeed,
different hypotheses exist to explain domain formation. The
raft hypothesis has two basic tenets (Simons and Ikonen,
1997): 1) that sterols and sphingolipids interact specifically
in biological membranes and 2) that their interaction causes
an increase in membrane lipid order, creating membrane
microdomains that affect protein function, diffusion, and/or
localization. To our knowledge, there is currently a lack of
evidence to demonstrate a specific role of lipid order in
biological membranes as postulated by the raft hypothesis.
Another hypothesis, known as the lipid shell hypothesis,
suggests that domains are formed through association of
specific lipids, in particular sterols and sphingolipids, with
proteins (Anderson and Jacobson, 2002).
There is clear biophysical evidence that sterols and sphin-
golipids can segregate from other lipids in simple artificial
membrane systems to form liquid ordered domains (Ahmed
et al., 1997). Sterol partitioning experiments between mem-
branes in vitro also suggest that they have affinity for mem-
branes with a high content of sphingolipids (Wattenberg
and Silbert, 1983). Sterols have been shown to have a con-
densing effect on artificial membranes (Radhakrishnan and
McConnell, 2005), and sterol-sphingomyelin–condensed
complexes have been characterized (Radhakrishnan et al.,
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2001). Some evidence exists in yeast suggesting a genetic
interaction between mutants in sterol and sphingolipid bio-
synthesis (Baudry et al., 2001; Eisenkolb et al., 2002; Jin et al.,
2008); however, little, if any, convincing evidence exists to
show that these two lipid species function together in com-
plex biological membranes. Therefore, the basic question of
whether sterols and sphingolipids interact functionally and
preferentially in biological systems remains unsolved and is
a major focus of this study.
Nevertheless, various lines of evidence suggest a possible
link between these two lipid classes. Sterols and sphingolip-
ids are concomitantly affected in certain diseases. In Ni-
emann Pick disease, although the primary defect is not yet
completely certain, defects in sphingolipid and cholesterol
trafficking appear to be interdependent (Puri et al., 1999;
Pagano et al., 2000; Vance, 2006). One of the proposed func-
tions of amyloid beta and presenilin is in control of sphin-
gomyelin and cholesterol amounts in the brain (Grimm et al.,
2005), which could affect the ontology of Alzheimer’s. Sphin-
golipid depletion has also been shown to influence the
SREBP pathway, controlling cholesterol and lipid biosynthe-
sis (Scheek et al., 1997).
In this study, we combine quantitative lipid analysis and
genetics in an unbiased approach to study yeast mutants in
sterol synthesis. This systematic analysis provides evidence
that yeast cells have a mechanism to respond to the presence
of specific sterol structures in their membranes and adjust
their sphingolipid composition accordingly. The genetic
analysis provides convincing evidence that sterols and
sphingolipids function together in cells to carry out multiple
functions. Furthermore, our results suggest that sterol and
sphingolipid structures have coevolved to provide optimal
interaction properties between the two lipid species. Our
results support the assertion of the raft hypothesis that
sterols and sphingolipids interact preferentially in biological
membranes; however, our initial studies of plasma mem-
brane fluidity suggest that the increased order that can be
induced by sterol–sphingolipid interaction is not the most
important factor for any of the several physiological read-
outs we have investigated.
MATERIALS AND METHODS
Strain Construction, Growth, Plating Assays, Protein
Extraction, and Western Blotting
All mutations were constructed using standard gene disruption procedures,
with complete removal of open reading frames, in our strain background.
Double mutants were obtained by genetic crosses. Strains are listed in Sup-
plementary Table S1. Cerulean (cyan fluorescent protein [CFP]; Rizzo et al.,
2004) was used to fluorescently tag Pdr12p in the genome using plasmid
pBS10 (Yeast Resource Center, University of Washington). Yeast were grown
in rich medium (1% yeast extract, 2% peptone, 2% glucose, and 40 mg/l uracil
and adenine) to log phase for lipidomic and sterol analysis. Forty OD600 units
of cells were harvested by centrifugation, washed with water, and frozen. For
the plating assays, yeast were grown to stationary phase and diluted to 107
cells per ml in water, and 10-fold serial dilutions were pinned onto agar plates
containing rich medium with additives adjusted to pH 5.5 (40 mM MES)
unless indicated. For Western blot analyses, proteins were extracted after
trichloroacetic acid denaturation as previously described (Urban et al., 2007).
Phospho-Ypk1 and phospho-Sch9 were detected using an anti-serum de-
scribed in Wanke et al. (2008). Anti-Ypk1 antiserum was purchased from
Santa Cruz Biotechnology (Santa Cruz, CA).
Lipid Standards
All lipid standards were obtained from Avanti Polar Lipids (Alabaster, AL),
with the exception of C19:0-ceramide and dioctanoyl glycerophosphoinositol
(GPIns), which were obtained from Matreya (Pleasant Gap, PA) and Echelon
Biosciences (Salt Lake City, UT), respectively.
Lipid Analysis by Electrospray Ionization–Mass
Spectrometry
Lipids were extracted from 40 OD600-equivalents of cells and as described
(Guan and Wenk, 2006), with the following modifications. Five micrograms of
dimyristoyl glycerophosphocholine (GPCho), 20 g of dimyristoyl glycero-
phosphoethanolamine (GPEtn), 4 g of dioctyl GPIns, 15 g of didocosa-
hexaenoyl glycerophosphoserine (GPSer), and 3 g of C19:0-ceramide were
added as internal standards. Quantification of individual molecular species
was carried out using multiple reaction monitoring (MRM) with a 4000
Q-Trap mass spectrometer (Applied Biosystems, Foster City, CA). Typically
25 l of samples was injected for analysis. The inlet system consisted of an
auto-sampler and a pump, and chloroform–methanol (1:1, vol/vol) at a flow
rate of 200 l/min was used as the mobile phase. In these experiments,
the first quadrupole, Q1, was set to pass the precursor ion of interest to the
collision cell, Q2, where it underwent collision-induced dissociation. The
third quadruple, Q3, was set to pass the structure-specific product ion char-
acteristic of the precursor lipid of interest. Each individual ion dissociation
pathway was optimized with regard to collision energy to minimize varia-
tions in relative ion abundance due to differences in rates of dissociation
(Guan and Wenk, 2006). Lipid levels were calculated relative to relevant
internal standards. Comparison of the means of wild-type and individual
genotypes from three independent experiments were performed. The quan-
tities of lipids are expressed as ion intensities relative to wild-type levels,
converted to a log10 scale. The difference in levels of individual lipid species
between wild-type and individual genotypes was determined statistically
using the Kruskal-Wallis test.
Sterol Analysis by Gas Liquid Chromatography–Mass
Spectrometry
Four micrograms of cholesterol standard were added to 40 A600 equivalents
of washed cells, and total sterols were extracted three times with petrol ether
after alkaline hydrolysis as described previously (Munn et al., 1999; Heese-
Peck et al., 2002). Total sterol extracts were taken up in 10 l pyridine and
silylated using 10 l of BSTFA (Sigma, St. Louis, MO). For gas-liquid chro-
matography–mass spectrometry (GC-MS) samples were diluted in ethyl ace-
tate and analyzed on an HP 5890 Series II gas chromatograph (Hewlett-
Packard, Palo Alto, CA) equipped with an HP 5972 mass selective detector
and an HP 5-MS column (cross-linked 5% phenyl methyl siloxane; dimen-
sions 30 m  0.25 mm 0.25-m film thickness). Aliquots of 1 l were
injected in the splitless mode at 270°C injection temperature with helium as
carrier gas at a flow rate of 0.9 ml/min in constant flow mode. The temper-
ature program was 1 min at 100°C, 10°C/min to 250°C, and 3°C/min to
310°C. Mass spectra were acquired in scan mode (range, 200–550 atomic mass
units) with 3.27 scans per second. Sterols were identified based on their mass
fragmentation pattern and retention time relative to the cholesterol standard
(Mullner et al., 2005).
Fluorescence Anisotropy Measurements
Cells were grown in YPD medium at 30°C to 1–5  107 cells/ml. After two
washes (10 mM Tris-Cl, 1 mM EDTA, pH 7.0), they were labeled with 0.5 M
of 1-[4-(trimethylamino)pheny]-6-phenyl-1,3,5-hexatriene (TMA-DPH; In-
vitrogen, Carlsbad, CA) at 25°C for 10 min. The sur2 strains were labeled with
2 M TMA-DPH. After two washes, the cells were placed in a RF-5300PC
spectrofluorometer (Shimadzu, Kyoto, Japan) fixed with a polarization unit.
The excitation and emission wavelengths were chosen at 358 and 458 nm and
measured 25°C. Anisotropy (r) was calculated from polarized intensities
according to the equation:
r  (IVV GIVH)/(IVV 2GIVH)
where I stands for fluorescence intensity of TMA-DPH–labeled cells after
subtraction of that of unlabeled cells. The subscript VV indicates measure-
ments with both polarizers positioned vertically, whereas subscript VH indi-
cates measurements with the excitation polarizer in the vertical and the
emission polarizer in the horizontal position. G stands for the G-factor,
IHV/IHH, for this instrument, where subscripts HV and HH indicate positions
of polarizers which are the opposite of VH and VV, respectively. Data are
represented as means  SDs from three independent experiments.
Fluorescent Microscopy Analysis
Yeast strains with plasmid pRS416-TAT2-mRFP (generated by subcloning the
HindIII-XbaI fragment from pMO10 (Okamoto et al., 2006) into pRS416 were
grown to log phase at 25°C in synthetic minimal medium lacking uracil and
tryptophan. TAT2- monomeric red fluorescent protein (mRFP) was observed
with a fluorescence microscope (BX51; Olympus, Tokyo, Japan). The fluores-
cence intensity of TAT2-mRFP in the plasma membrane and vacuole was
quantified by a Slide Book 4 Digital Microscopy software (Intelligent Imaging
Innovations, Denver, CO) and expressed as a percentage of total intensity.
The data are shown as means  SDs from n  27–59 cells. Yeast strains with
plasmid Can1-green fluorescent protein (GFP) were grown in minimum
media at 30°C to exponential phase (OD600  0.7) and resuspended in
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potassium phosphate buffer (pH 7.0). Live specimens were visualized using
Zeiss 510 Meta confocal microscope (Thornwood, NY) with a 100 PlanApo-
chromat objective (excitation 488 nm). Image processing was done with Image
J (http://rsb.info.nih.gov/ij/). To examine patches on the plasma membrane
Z-stacks were created to generate images of entire cells and confocal sections
of the cell surface were visualized (data not shown). Fluorescence images of
Pdr12-CFP were all acquired using the same exposure time.
Transcript Analysis
Yeast strains were grown in triplicate in exactly the same conditions (unique
batch of YPUAD, same day) until an OD600 of 0.8–1.0 was reached. Two ml of
culture was centrifuged; cells were frozen in liquid N2 and stored at80°C. Total
RNA extraction was performed using the RNeasy Mini Kit (No. 74104; Qiagen,
Chatsworth, CA) mechanical disruption protocol including a column DNAse
treatment.
RNA purity was controlled on a spectrophotometer; the ratios A260/A280
(protein contamination) and A260/A230 (guanidinium thiocyanate contamina-
tion) were more than or equal to 2.0. RNA integrity control was performed by
capillary electrophoresis on an Agilent Technologies 2100 Bioanalyzer (Wilming-
ton, DE).
Five hundred nanograms of RNA was amplified and labeled using Mes-
sageAmp II-Biotin Enhanced (No. AM1791; Ambion, Austin, TX). Biotin-
labeled cRNA, 20 g, was fragmented and hybridized for 16 h to Affymetrix
GeneChip Yeast2.0 Array (Affymetrix, Santa Clara, CA). The hybridization
and development with streptavidin was performed using GeneChip Hybrid-
ization Wash and Stain Kit (No. 900720; Affymetrix). Washing and develop-
ment of the chip was done on GeneChip Fluidics Station 450. Three biological
replicates were processed for each strain.
Microarray Analysis
Summarization and normalization (scaling) of the microarray data were
conducted using GCOS (Affymetrix). The software package GeneSpring GX
7.3 Analysis Platform (Agilent Technologies) and Matlab 2008 (MathWorks,
Natick, MA) were then used to analyze the microarray data. Microarray
expression ratios were presented as log-transformed base 2. Hierarchical
clustering analysis focused on transcript expression patterns rather than
absolute values and the triplicate data over each strain was averaged using
the mean in the log2 transform matrix. The average of each strain (i.e., every
probeset) was then subtracted from the averaged value of the wild-type strain
in the gene expression matrix. The rows were then clustered using a correla-
tion similarity metric and the average linkage method in Matlab.
RESULTS
Sterol Biosynthesis Mutants Show Altered Sphingolipid
Profiles
Mutants in the last five steps of ergosterol synthesis (Figure
1; Supplementary Figure S1) lead to a wide variety of phe-
notypes. We have created an isogenic set of single and
double mutants in ergosterol biosynthesis and have charac-
terized them for their sterol compositions and endocytic
phenotypes (Munn et al., 1999; Heese-Peck et al., 2002). We
noticed that the double erg3 erg6 mutant, which has a sub-
stantial growth defect, showed changes in its sphingolipid
metabolism (Supplementary Figure S2) and that this change
could be reversed by mutation of the yeast sphingomyeli-
nase homolog (Sawai et al., 2000) encoded by ISC1 (Figure 1).
The mutation in ISC1 aggravated the growth defect of the
erg3 erg6 double mutant at 37°C (Supplementary Figure S2).
These data suggest a functional interaction between sterols
and sphingolipids, but this particular case might not be
representative. Therefore, we systematically examined the
lipid composition of all of our erg mutants using electros-
pray ionization–mass spectrometry (ESI-MS) techniques.
The erg mutants (Supplementary Table S1) were grown in
rich medium to log phase, harvested, washed, and frozen.
Internal standards for quantitation were added, and the
lipids were extracted and quantified by ESI-MS (Guan and
Wenk, 2006). The quantification of the major glycerophos-
pholipids (except for cardiolipin) and several of the major
sphingolipids are presented. Results on mannosyldiinositol-
phosphorylceramide (M(IP)2C) are not presented because
the data were not easily interpretable because of the pres-
ence of singly and doubly charged species, together with the
fact that no appropriate internal standard was available. By
steady-state phosphate or inositol labeling and thin-layer
chromatography analysis, M(IP)2C represents 20% of the
total sphingolipids in Saccharomyces cerevisiae (Schorling et
al., 2001). Quantification was carried out relative to wild-
type cells and is presented in Figure 2. The single erg mu-
tants showed substantial changes (30%) in 10% of their
glycerophospholipid species, but showed substantial
changes in more than 45% of their sphingolipid species.
Remarkably, the sphingolipid pattern found in each single
erg mutant was different. Therefore, the changes cannot be
due to a lack of ergosterol because none of the mutant
strains have ergosterol, but should be due to the presence of
the abnormal sterols. This astounding result implies that
yeast cells have the capacity to modify their sphingolipid
composition in response to changes in sterol structures in
their membranes. Many of the sterols accumulated in the
mutants represent natural biosynthetic intermediates of er-
gosterol biosynthesis and are also found at low levels in
wild-type cells (Supplementary Table S2). It is unlikely that
Figure 1. Structures of some abundant sphingolipid,
sterol, and glycerophospholipid species in S. cerevisiae.
ISC1 encodes an inositolphosphorylceramide (IPC) hy-
drolase that converts IPC to ceramide and inositol phos-
phate. SUR2 and SCS7 encode enzymes responsible for
hydroxylation of the sphingoid base and fatty acid,
respectively, of sphingolipids. The last five steps of
ergosterol biosynthesis are shown. The order of events
is not implied here. For comparison, we show one of the
most abundant yeast glycerophospholipids, 34:1 phos-
phatidylinositol. For details see Supplementary Figure
S1. Structures were drawn with ACD/ChemSketch
freeware.
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cells are reacting to the concentration of sterols in the mem-
brane because the total amount of sterols present in the
single erg mutants was always higher than in the wild-type
(Supplementary Table 2).
Double mutants in ergosterol biosynthesis have substan-
tial changes in their sphingolipid pattern, but also have
substantially more changes in their glycerophospholipids
(Figure 2). The single erg6 mutant appears somewhat inter-
mediate in its lipid pattern between the single and double
erg mutants. This is probably due to the fact that the ERG2
gene product works very inefficiently in the erg6 mutant
strain, as noted by the accumulation of sterols with a double
bond at position 8 (Heese-Peck et al., 2002; Supplementary
Table S2E), explaining why the erg6 mutant has partial prop-
erties of a double erg2 erg6 mutant. Consistent with the
radioactive labeling experiments, most of the double mu-
tants as well as the erg2 and erg6 strains have less of the
major inositolphosphoceramide (IPC) species, IPC-C. Other-
wise, the patterns of sphingolipid prevalence vary consid-
erably. Interestingly, when mutations in sphingolipid hy-
droxylation or head group turnover are introduced, there
are no major changes in sterol compositions or quantities
(Supplementary Table S2A). Most double erg mutants show
more substantial changes in their sphingolipid patterns than
either of the corresponding single erg mutants. There is one
notable exception to this, the erg5 erg6 mutant, whose sphin-
golipid pattern is closer to wild type than either of the two
single mutants. This might have evolutionary significance
(see Discussion).
Sterol and Sphingolipid Biosynthesis Pathways Interact
Genetically
The specificity of the sphingolipid patterns in the different
single erg mutants suggests that these changes may be a
physiological response to accumulation of sterol biosyn-
thetic intermediates and led us to hypothesize that sterols
Figure 2. Lipidome of mutants in ergosterol
biosynthesis. Isogenic wild-type and ergos-
terol mutant strains were grown as indicated.
Lipid standards were added to 50 OD600-
equivalents of cells, and lipids were extracted
and measured using ESI-MS (Guan and
Wenk, 2006). The quantities of lipids are ex-
pressed as ion intensities relative to wild-type
levels, converted to a log10 scale. Glycero-
phospholipids: GPCho, glycerophosphocho-
line; GPEtn, glycerophosphoethanolamine;
GPIns, glycerophosphoinositol; GPSer, glyc-
erophosphoserine. Sphingolipids: IPC, inositol
phosphorylceramide; MIPC, mannosyl inositol
phosphorylceramide. The suffixes -B, -C, and -D
on IPC and MIPC denote hydroxylation states,
having two, three, or four hydroxyl groups, re-
spectively. Data are presented as means of three
independent biological samples. Statistical sig-
nificance between wild-type and individual ge-
notypes was determined using the Kruskal Wal-
lis test. * p  0.05.
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and sphingolipids functionally interact in yeast cells. To test
this hypothesis, we created isogenic double mutants in sterol
and sphingolipid biosynthesis. The prediction is that simul-
taneous defects in both pathways should lead to synthetic
phenotypes. The changes in sphingolipid patterns (Figure 2)
are mainly associated with changes in sphingolipid hy-
droxylation or in head group composition. Therefore, we
chose a mutant that affects sphingolipid head group turn-
over, isc1, and mutants affecting sphingolipid hydroxyla-
tion. The sur2 mutant is unable to hydroxylate the sphingoid
base and the scs7 mutant is defective in hydroxylation of the
fatty acid on sphingolipids (see Figure 1 and Supplementary
Figure S1; Haak et al., 1997). We made all 15 possible double
mutant combinations of the five single erg mutants, with the
three mutants affecting sphingolipid metabolism, and ana-
lyzed their ability to grow under a number of conditions. All
of the single erg mutants, with or without sphingolipid
defects, grew well at 30°C on rich medium, as do all of the
double erg mutants except erg2 erg6 (Figure 3). At 37°C or on
plates with nonfermentable carbon sources, several double
mutants showed reduced growth when compared with the
corresponding single mutants (marked with arrows). The
double erg mutants notably exhibited more severe pheno-
types than the single erg mutants from which they were
derived.
The mutants were next assayed for growth under a wide
variety of conditions in order to uncover new phenotypes
(Supplementary Figure S3). Some particularly illustrative
examples from these assays are shown. Blocking hydroxy-
lation of either the sphingoid base or the fatty acid of sphin-
golipids is able to suppress the slow growth phenotype of
the erg2 mutant at 16°C (Figure 4A). The results found at
16°C are quite atypical, because changes in hydroxylation
usually have much more specific effects on strains with
aberrant sterols (Figure 4B). Combination of a mutation in
sphingolipid fatty acid hydroxylation (scs7) with the erg2
mutation completely abrogates growth on plates with low
amounts of caffeine, an inhibitor of the Target of Rapamycin
Complex (TORC) 1 signaling pathway (Reinke et al., 2006),
whereas both corresponding single mutants grow well on
caffeine plates. A similar result was found for sensitivity to
rapamycin (see below). Combination of sur2 with erg3 or
erg6 led to synthetic growth phenotypes on plates with a low
concentration of a glycosylphosphatidylinositol synthesis
inhibitor, YW3548 (Sutterlin et al., 1997) or a low concentra-
tion of SDS (Figure 4C, left and right, respectively). These
Figure 3. Systematic phenotypic analysis.
The indicated strains were grown and pinned
onto YPD or YPEG (1% yeast extract, 2% pep-
tone, 3% ethanol, 3% glycerol, and 40 mM
MES, pH 5.5) plates and grown at 30°C except
when indicated. Plates were photographed af-
ter 2 (30 and 37°C) or 4 d (YPEG). Arrows
denote conditions where sterol–sphingolipid
double mutants showed different growth than
the single erg mutants under the conditions
shown. Each asterisk represents where the
double mutant shows a change in growth
properties (synthetic growth defect or sup-
pression) when compared with the single erg
mutant (Supplementary Figure S3). Of the 15
double mutants constructed, 13 showed syn-
thetic phenotypes.
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conditions are both expected to induce cell wall defects. The
specificity of the site of hydroxylation in combination with
particular sterol biosynthesis mutations suggest that it is the
combination of the structures that leads to the synthetic
phenotype. The simplest way to interpret this would be to
postulate that sphingolipids and sterols interact physically
in membranes to carry out some of their required functions.
At the very least, we can conclude that they work in com-
mon pathways.
Sorbic acid resistance is conferred by an ATP-dependent
pump, Pdr12p (Piper et al., 1998), which exports weak acids
such as sorbic and benzoic acids. This process is most af-
fected by the erg3 and erg6 mutations (Supplementary Fig-
ure S3), suggesting that a 	5 double bond in the B-ring and
methylation of the side chain of ergosterol are the most
important features for Pdr12p function. The erg4 mutant
strain grows weakly on 1 mM sorbic acid plates, but com-
bination with the sur2 mutation completely abrogates
growth (Figure 4D). Introduction of the isc1 mutation im-
proves growth slightly under the same conditions. The ef-
fects of sphingolipid changes on the erg5 mutant are quite
different. The sur2 and scs7 mutations have almost no effect
on growth of erg5 cells on sorbic acid plates, whereas intro-
duction of the isc1 mutation completely blocks growth under
the same conditions. These data show that the isc1 mutation
is not having a simple positive or negative effect that is
added to the effect of the sterol mutant. These results further
confirm that it is the specific combinations of sphingolipid
and sterol structures that lead to the synthetic phenotypes.
By using very simple tests we found synthetic phenotypes
in 13 of the 15 possible double mutants in ergosterol and
sphingolipid biosynthesis (Figure 3), providing genetic
proof that these two pathways work together to carry out
multiple cellular functions. A possible explanation for the
genetic interaction could be that creation of the double mu-
tants causes additional changes in glycerophospholipids
and/or sterols. To examine this, we analyzed the glycero-
phospholipids, sphingolipid, and sterol compositions in the
double mutant strains by ESI-MS. As expected from the
introduction of mutations in sphingolipid modification, we
observed dramatic changes in the sphingolipid pattern, but
relatively minor changes in the phospholipids or sterols
(Supplementary Figure S4 and Supplementary Table S2),
lending additional support to our conclusion that it is the
structural interactions between the sterols and sphingolipids
in the membrane that cause the synthetic phenotypes and
not further changes in phospholipids or sterols.
In this study, we have established that sterols and sphin-
golipids function together. We next sought to characterize
the lipid dependence of two phenotypes to demonstrate
how the combination of sterols and sphingolipids can affect
the manner in which cells respond to drugs. The first exam-
ple is the hypersensitivity of sterol–sphingolipid mutants to
caffeine and rapamycin, and the second example is the hy-
persensitivity to sorbic acid.
Reduced TORC2 Activity Causes Caffeine and Rapamycin
Hypersensitivity
TORC1 is the target of caffeine and rapamycin in yeast both
in vivo and in vitro (Wanke et al., 2008), whereas TORC2 is
not significantly inhibited by either drug. Inhibition of
TORC1 yields profound changes in the transcriptome, in-
cluding a striking down-regulation of genes encoding ribo-
somal proteins (Martin et al., 2004; De Virgilio and Loewith,
2006). Therefore, we first examined expression of ribosomal
protein mRNAs in our different strains to determine if re-
duced TORC1 activity could explain the increased caffeine
sensitivity. Levels of mRNAs encoding ribosomal proteins
were not affected in any of the mutants where transcript
profiles were examined, including erg2 scs7 cells (see data at
ArrayExpress at EBI, Experiment Riezman, Accession no. ID
E-TABM-544). Surprisingly, when genes that were specifi-
cally overexpressed in the erg2 scs7 mutant were examined,
we found RTA1, a gene that seems to be repressed by
TORC2 (Mulet et al., 2006). On further inspection, a tight
cluster of genes that are negatively regulated by TOR2 was
found to be overexpressed in the erg2 scs7 mutant specifi-
cally (see Figure 7 and Supplementary Figure S5), suggest-
ing that TORC2 might be less active in the mutant. This is
the case because Ypk1p, one of the two Ypk kinases directly
phosphorylated by TORC2 (Kamada et al., 2005; M. Picolis
and R. Loewith, unpublished data) is hypophosphorylated
in the mutant (Figure 5A). Sch9p, a direct TORC1 target
(Urban et al., 2007), is phosphorylated normally in these
strains, confirming that TORC1 is active. These results and
the previous observation that ypk1 mutant cells are hyper-
sensitive to rapamycin (Gelperin et al., 2002) suggest that
reduced TORC2 activity and hypersensitivity to caffeine and
Figure 4. Examples of suppression and synthetic phe-
notypes. Dilutions of indicated strains were spotted
onto plates under the following conditions; 16°C (A),
2 mM caffeine (B), 1 g/ml YW3548 (C, left), 0.01% SDS
(C, right) or 1 mM sorbic acid at pH 4.5 (D).
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rapamycin might be related. To investigate this, we intro-
duced a plasmid carrying a constitutively active Ypk2 allele
(Kamada et al., 2005) to bypass TORC2 function into the set
of erg2 and scs7 mutant strains. The results were very clear.
Ypk2 kinase activity suppressed the hypersensitivity of the
erg2 scs7 strain to caffeine and rapamycin (Figure 5B). These
results demonstrate that combination of the erg2 and scs7
mutations renders yeast cells hypersensitive to caffeine and
rapamycin by lowering TORC2 activity. Strikingly, the ste-
rol–sphingolipid composition affects how cells respond to
these two drugs, not by affecting the direct target of the
drug, but by affecting a partially overlapping pathway.
Reduced Activity of Pdr12p Causes Sorbic Acid
Sensitivity
Sorbic acid is a commonly used food preservative that dif-
fuses into cells when protonated at low pH and is trapped
internally when it becomes deprotonated. It can be detoxi-
fied by yeast cells via the multidrug resistance (MDR)-like
transporter, Pdr12p (Piper et al., 1998) in an ATP-dependent
manner. To examine Pdr12p localization and function, we
constructed a C-terminal genomic fusion creating a func-
tional, fluorescently labeled Pdr12::CFP. Sorbic acid induces
Pdr12p expression, and the protein is delivered to the cell
surface (Piper et al., 1998) where it is the major, if not only
protein that exports weak organic acids, including sorbic
and benzoic acids as well as fluorescein (Holyoak et al.,
1999). In wild-type, erg4, sur2, and erg4 sur2 mutants, Pdr12-
CFP was induced and transported to the cell surface in
approximately equal amounts as determined by fluores-
cence microscopy (Figure 6A). Pdr12p activity was assayed
by measuring export of fluorescein. Fluorescein diacetate
was loaded into yeast in the absence of glucose, conditions
where export is defective. Glucose was added to allow flu-
orescein export. The double erg4 sur2 mutant showed dras-
tically reduced fluorescein export, approximately six times
less efficient than wild-type cells (Figure 6B). These results
show that the MDR-like protein, Pdr12p, is properly trans-
ported to the cell surface, but is not active if membranes lack
functional sterol–sphingolipid structures. In this example,
sterol–sphingolipid composition seems to affect the drug
export protein in a fairly direct manner.
Plasma Membrane Transporters and Anisotropy
Next, we turned our attention to protein trafficking where
raft structures have been proposed to play an important
role. We examined all of the single and double mutants and
tested whether membrane protein-trafficking defects corre-
lated with anisotropy measurements of the plasma mem-
brane. One of the best established systems where proteins
have been localized to specific plasma membrane microdo-
mains is in S. cerevisiae, where two distinct types of domains
have been seen. One of these is patches of 300 nm on the
cell surface that contain the various permeases, including
the tryptophan transporter Tat2p and the arginine trans-
porter Can1p. Both transporters have been reported to be
resistant to cold-detergent extraction, a technique that is
often correlated with presence in rafts (Malinska et al., 2003,
2004; Umebayashi and Nakano, 2003; Mayor and Riezman,
2004). The permease-containing plasma membrane patches
also stain for filipin, indicating the presence of ergosterol
(Malinska et al., 2003, 2004). More recently, it has been
shown that many genes, including some involved in sterol
Figure 5. Hypersensitivity to caffeine and rapamycin is due to
decrease in TORC2 activity. (A) Protein extracts were prepared from
log phase cultures of wild-type, erg2, scs7, and erg2 scs7 mutant
strains. The extent of phosphorylation of the hydrophobic motifs in
Ypk1 and Sch9 (indicative of TORC2 and TORC1 activity, respec-
tively) were determined by SDS-PAGE and Western blotting. Rapa-
mycin treatment was for 20 min with 200 ng/ml. B) The same yeast
strains, transformed with empty vector (Yep352) or an activated
allele of Ypk2p (Yep352::Ypk2D239A-HA were grown to stationary
phase, diluted, and 10-fold serial dilutions were plated onto plates
containing 2 mM caffeine or 20 ng/ml rapamycin.
Figure 6. Sorbic acid sensitivity in erg4 sur2 is due to defective
export by Pdr12p. (A) Pdr12p-CFP was visualized in the indicated
strains. (B) The same strains were loaded with fluorescein diacetate
in the presence of 2-deoxygluose to deplete ATP. The cells were
harvested and resuspended in glucose containing medium and
extracellular fluorescein was quantified after 15 and 30 s. Relative
rates of FDA export per minute are shown. * p  0.05 by the t test
for mean.
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metabolism, affect the protein composition and structure of
these patches (Grossmann et al., 2008). The permease-con-
taining patches are surrounded by membrane domains con-
taining the plasma membrane ATPase, a protein that has
also been claimed to be functionally associated with rafts for
biosynthetic delivery to the cell surface (Bagnat et al., 2000;
Bagnat and Simons, 2002). Therefore, we analyzed the local-
ization of fluorescently tagged Tat2p and Can1p, proteins
found in the same domains at the cell surface. In wild-type
cells under our conditions, Tat2p is found in approximately
equal amounts in the plasma membrane and in the vacuole.
The vacuolar Tat2p may be generated by direct targeting
from the biosynthetic pathway or via delivery to the cell
surface and subsequent endocytosis. Cell surface and vacu-
olar Tat2-GFP in the various mutants were quantified (Sup-
plementary Figure S5; Table 1). The single erg mutants as
well as isc1 and sur2 increased the amount of Tat2-GFP in
the vacuole, and several strains showed slight endoplasmic
reticulum (ER) accumulation. The increase in vacuole local-
ization in the erg3 mutant is partially suppressed by the scs7
mutation, whereas the increase in vacuolar localization in
the erg6 mutant is enhanced by isc1 and sur2 mutations. This
demonstrates suppression and synthetic effects also for pro-
tein localization. On the other hand, the effects on Can1-GFP
localization are only minor. In all mutants we detected the
majority of Can1-GFP at the plasma membrane (Supplemen-
tary Figure S5). In the erg2 and erg3 series we found a small
amount of vacuole staining, but no synthetic phenotypes
(Table 1). The Can1-GFP construct was active in all strains
because it conferred canavanine sensitivity. Therefore, two
proteins localizing to the same plasma membrane patches
seem to have quite different sterol and sphingolipid require-
ments.
Very recently, Walther’s group has proposed that TORC2
localizes to a third membrane domain (Berchtold and
Walther, 2009). It will be of interest to determine if the
localization of TORC2 to this domain is specifically altered
in erg2 scs7 cells.
Because most of the plasma membrane surface is covered
by proteins that have been proposed to localize to rafts, we
decided to measure the fluorescence anisotropy of the
plasma membrane using TMA-DPH. This fluorescent probe
inserts into the yeast plasma membrane and measurement of
its anisotropy correlates with membrane rigidity or lipid
order (Sharma, 2006). The lower the anisotropy is, the more
fluid is the membrane. Many of the erg mutants showed
significantly and substantially lower anisotropy than wild-
type cells, in particular, erg6 (Table 2). Interestingly, all of the
double mutants with erg6 showed increased anisotropy,
whereas they showed a greater defect in Tat2p surface lo-
calization and frequently exhibited more severe phenotypes
in other assays performed in this study (Supplementary
Figure S3). These results indicate that changes in sterol and
sphingolipid composition definitely do affect membrane flu-
idity; however, there was a lack of correlation between the
magnitude of these changes with any other phenotypic pa-
rameter that we have measured. From this systematic and
unbiased approach to examine a role for membrane order on
processes that depend upon the sterol and sphingolipid
composition, we have to conclude that the fluidity/rigidity
(order) of the membrane is not the major determinant in the
phenotypes that we measured. This calls into question
whether the lipid order predicted to be induced by sterol–
sphingolipid interactions in the plasma membrane plays an
important physiological role.
Transcriptome of Sterol and Sphingolipid Biosynthesis
Mutants
To begin to understand the basis for some of the phenotypes
we observed in this study and the mechanism whereby cells
change their sphingolipid composition in response to their
sterol compositions, we performed transcript analysis of
Table 1. Summary of Tat2p and Can1p localization data
Tat2 localization Can1p localization
Genotype PM Vacuole SD PM Vac Small patches Large patches
wt 46 54 6 Mostly No Yes Yes
isc1 28 72 5 Mostly No Yes No
sur2 35 65 6 Mostly No Yes No
scs7 41 59 5 Mostly No Yes No
erg2 35 65 6 Mostly No Yes Yes
erg2 isc1 36 64 8 Mostly Yes Yes No
erg2 sur2 34 66 6 Mostly Yes Yes No
erg2 scs7 34 66 6 Mostly Yes Yes Yes
erg3 28 72 5 Mostly Yes Yes Yes
erg3 isc1 24 76 5 Mostly Yes Yes Yes
erg3 sur2 26 74 7 Mostly Yes nd nd
erg3 scs7 37 63 7 Mostly Yes nd nd
erg4 34 66 6 Mostly No Yes Yes
erg4 isc1 47 53 4 Mostly No Yes Yes
erg4 sur2 35 65 7 Mostly No Yes No
erg4 scs7 38 62 6 Mostly No Yes No
erg5 33 67 5 Mostly No No Mainly
erg5 isc1 36 64 5 Mostly No Yes Yes
erg5 sur2 37 63 4 Mostly No Yes Yes
erg5 scs7 35 65 5 Mostly No Yes Yes
erg6 35 65 6 Mostly No Yes Yes
erg6 isc1 24 76 6 Mostly No Yes Yes
erg6 sur2 24 76 6 Mostly No Yes Yes
erg6 scs7 34 66 7 Mostly No Yes Reduced
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wild-type cells and 15 of the single and double mutants.
Many sets of genes were unaffected by the mutations. These
include genes required for the general secretion machinery,
unfolded protein response, cell cycle machinery, large and
small ribosome subunits, and many genes required for vac-
uole biogenesis (see data at ArrayExpress at EBI, Accession
ID E-TABM-544). We eliminated all genes that did not show
at least a twofold change under one condition and then
clustered the genes together by expression pattern in the
different strains using the correlation distance algorithm
(Figure 7). Different patterns can be distinguished. For ex-
ample, one set of genes is overexpressed in all erg2, erg3, and
erg6 mutants and is relatively unaffected by mutations in
isc1, sur2, or scs7. This set is characterized by a large number
of genes related to ergosterol biosynthesis and genes ex-
pressed during anaerobic growth, suggesting that these
genes are coregulated by sterol composition. Another set of
genes, involved in mating, shows the same pattern of regu-
lation, but is underexpressed. The largest set, mainly com-
prising genes induced by stress responses (e.g., heat-shock
proteins, trehalose synthesis, glycerol synthesis, and auto-
phagy) is characterized by overexpression in isc1, erg2, and
erg6 strains, but with only mild, if any, overexpression in the
erg3, erg4, or erg5 strains. In this set, synthetic and suppres-
sive effects due to combination of sterol and sphingolipid
mutations can be seen. For example, strong overexpression
of many stress genes are seen in isc1, erg2, and erg6, but
combination of the isc1 mutation with either erg2 or erg6
usually results in less overexpression. The effect of the sur2
mutation on overexpression is less than the isc1 mutation.
However, combination of sur2 with either erg2 or erg6 results
in stronger overexpression than the corresponding isc1 dou-
ble mutants. It is clear from these results that most of the
phenotypes we have identified with our plate assays do not
correlate with induction of stress genes and therefore are
probably not an indirect result of cellular stress. Again,
another set of genes, involved in ribosome biogenesis and
RNA processing, shows the same pattern, but with under-
expression. Genes negatively regulated by TORC2 are over-
expressed most strongly in the erg2 scs7 mutant. Several
genes regulating products stored in the yeast vacuole (phos-
phate, basic amino acids) are affected. Genes involved in
phosphate metabolism and storage are strongly down-reg-
ulated by sphingolipid mutations and display a particularly
strong phenotypic enhancement when the erg2 and scs7
mutations are combined. The erg3 mutation causes some
down-regulation, but the erg6 mutation causes a small up-
regulation. Two other groups that form clusters are genes
involved in basic amino acid biosynthesis, but interestingly,
genes required for arginine biosynthesis are regulated dif-
ferently from those for lysine biosynthesis. Several other
smaller clusters can be seen and are noted (Supplementary
Figure 6).
We examined if changes in transcript profiles in the erg
mutants could explain the changes in sphingolipid compo-
sition. Of the more than 20 genes involved in sphingolipid
biosynthesis and degradation (Supplementary Figure S1),
we found four genes whose transcript levels changed sig-
nificantly. Three of these are involved in sphingolipid deg-
radation. YDC1 and YPC1, the two ceramide hydrolases, are
coregulated with stress genes. YSR3, one of two sphingoid
base phosphate phosphatases is coregulated with sterol bio-
synthesis genes. Finally, SUR1, encoding the catalytic sub-
unit of one of the two mannosyltransferases making MIPC,
is up-regulated in all strains tested, except the scs7, erg3, and
erg5 mutants. These results strongly suggest that the
changes in sphingolipid composition seen in the erg mutants
are not the results of transcript changes.
DISCUSSION
One of the major new findings emanating from this study is
that cells have a mechanism to sense and react to changes in
their membrane sterol composition by modifying their
membrane lipid compositions affecting mainly sphingolip-
ids. The mechanism of the adaptation of sphingolipid levels
is not understood yet, but is most likely not uniquely due to
differences in transcript levels of the different genes involved
in the pathway as most of the genes were unchanged. The
mechanism used to detect the changes in sterol composition
is currently under study and genetic approaches are possi-
ble. It is not the absence of ergosterol that is sensed, because
each erg mutant shows a different pattern of sphingolipids.
The pathway leading to changes in sphingolipid composi-
tion is most likely fundamentally different from previously
described sterol-sensing mechanisms where different
amounts of cholesterol are sensed by the SREBP pathway or
other sterol sensors and then control gene expression (Gold-
stein et al., 2006), because sterol intermediates, rather than
the total quantity of sterols, seem to affect sphingolipid
composition in different ways and the changes are unlikely
brought about directly through changes in gene expression.
Recently, an SREBP-dependent pathway has been described
in Schizosaccharomyces pombe, which has several features in
common with what we have seen here, because there is a
coordinate regulation of anaerobically expressed genes with
ergosterol biosynthesis genes (Todd et al., 2006; Figure 7)
and because sterol biosynthesis intermediates seem to be
important (Hughes et al., 2007), but no specific effects on
sphingolipids have been described. The pathway cannot be
identical in S. cerevisiae because this yeast does not have an
SREBP homolog, although they do have oxysterol-binding
proteins that have been proposed to be involved in intracel-
lular sterol transport (Raychaudhuri et al., 2006).
Table 2. Anisotropy measurements using TMA-DPH
Genotype Mean SD Significance
WT 0.283 0.004
isc1 0.278 0.005 p 0.2
scs7 0.284 0.011
sur2 0.270 0.015 p 0.2
erg2 0.274 0.008 p 0.2
erg2 isc1 0.267 0.014 p 0.2
erg2 sur2 0.276 0.005 p 0.2
erg2 scs7 0.275 0.010
erg3 0.276 0.009
erg3 isc1 0.270 0.015
erg3 sur2 0.273 0.006 p 0.1
erg3 scs7 0.291 0.010
erg4 0.280 0.006
erg4 isc1 0.268 0.006 p 0.05
erg4 sur2 0.291 0.012
erg4 scs7 0.278 0.008
erg5 0.276 0.004 p 0.2
erg5 isc1 0.285 0.005
erg5 sur2 0.279 0.019
erg5 scs7 0.277 0.005 p 0.2
erg6 0.249 0.015 p 0.05
erg6 isc1 0.265 0.008 p 0.05
erg6 sur2 0.270 0.008 p 0.1
erg6 scs7 0.268 0.009 p 0.1
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An interesting question is the physiological significance of
the adaptation mechanism. First, it is likely that natural
intermediates in the ergosterol biosynthesis pathway are
being recognized. They are present in significant amounts
under normal growth conditions and are found in larger
amounts in the erg mutants (Supplementary Table S2). Sterol
biosynthetic intermediates have been shown to be localized
preferentially to the ER membrane (Zinser et al., 1993), and
their amounts could be important in regulating adaptation
mechanisms. Second, yeast may frequently encounter azole
and other inhibitors of ergosterol biosynthesis in their nat-
ural environment and therefore require adaptation mecha-
nisms to adjust their sphingolipid composition when azole
compounds are present and inhibit sterol biosynthesis at
various steps.
The control of sphingolipid species is unlikely to be solely
the result of transcriptional changes because few differences
in sphingolipid metabolic enzymes were observed. In par-
ticular, some changes in sphingolipid content are likely to be
due to head group turnover via Isc1p (Supplementary Fig-
ure S2). The mode of activation of Isc1p in this case is
unknown, but one possibility is regulation by localization
because its localization has been shown to change as a result
of changes in culture conditions in yeast (Vaena de Avalos et
al., 2004).
In contrast to the effect of sterol mutations on sphingolipid
composition, mutations affecting hydroxylation and head
group turnover of sphingolipids do not seem to affect the
sterol composition. Therefore, this process is not reciprocal.
There could be different explanations for this situation. First,
the species of sphingolipids that change in the sterol mu-
tants are sphingolipid species that are normally present in
substantial quantities, and only their amount changes. They
cannot all be considered as intermediates, because each of
these sphingolipid species might be functional. Known an-
tifungals that target the sphingolipid biosynthesis pathway
act at or before the step of inositolphosphorylceramide (IPC)
synthesis (Horvath et al., 1994; Mandala and Harris, 2000;
Figure 7. Cluster map of transcripts that
change in the sterol and sphingolipid mutants.
Transcript levels were determined in the indi-
cated strains. Data for transcripts that changed
at least twofold under one condition were
clustered. Predominant characteristics of gene
clusters are indicated on the right. An expand-
able version of the figure with gene names or
identifiers is provided (Supplementary Figure
S6). The scale is a log transformed base 2.
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Sugimoto et al., 2004). In contrast, the major sterol species is
ergosterol, and other species are probably just intermediates
in its biosynthesis. Second, during evolution some metazo-
ans either never had or lost the ability to synthesize sterols
and are sterol auxotrophs (Vinci et al., 2008). Two particu-
larly well-studied systems are Drosophila and Caenorhabditis
elegans (Silberkang et al., 1983; Matyash et al., 2001). Experi-
ments with Drosophila did not detect any major changes in
phospholipid head groups or acyl group composition when
grown with different amounts of cholesterol (Silberkang et
al., 1983). Sphingolipids were not examined in this study. No
information is published yet from either system about the
lipid composition of these organisms when they are grown
using different sterols. It is possible that these organisms
have a mechanism similar to that described here for yeast
that could be used to adjust membrane composition in re-
sponse to which sterols they ingest.
The specific and major changes in sphingolipid species
when sterol intermediates are present in the membrane
show a dependence of sphingolipid metabolism on sterol
composition, but also suggest that sterols and sphingolipids
function together. The second major finding from our study
stems from our genetic analysis of double mutants in sterol
and sphingolipid metabolism and provides proof for their
functional interaction. This study revealed a number of
novel synthetic and suppression phenotypes between sterol
and sphingolipid biosynthesis mutants. Two aspects of this
systematic and unbiased analysis are particularly convinc-
ing. First is the penetration of phenotypes, with 13 of the 15
possible double mutants showing synthetic or suppression
phenotypes. Second is the astounding specificity of the com-
binations required to affect each phenotype and the strict
specificity for the site of hydroxylation on the sphingolipid
molecule and its combination with a particular sterol muta-
tion. Synthetic phenotypes can occur for different reasons:
when there are two parallel pathways and one mutation is in
each pathway or when two mutations affect the same path-
way, quite often at the same step. Each mutation would
affect the step partially, but the double mutant would have
a much stronger phenotype. Classically, this can result when
two proteins work together as a complex. In a similar man-
ner it is possible to interpret our data by suggesting that
sterols and sphingolipids might function in a variety of
pathways as a sterol–sphingolipid complex. Sterols and
sphingolipids are clearly capable of forming condensed
complexes in artificial membranes (Radhakrishnan et al.,
2000), and there is no reason to expect that they should not
be able to do the same in biological membranes.
We tested many different phenotypes including growth in
presence of cell wall disturbances, weak organic acid sensi-
tivity, different carbon sources, temperatures, various
classes of inhibitors affecting a number of different pathways
as well as a systematic analysis of transcript levels. It is
virtually impossible that sterols and sphingolipids happen
to act in parallel pathways to carry out each of these func-
tions where synthetic phenotypes have been uncovered.
Therefore, we are obliged to conclude that sterols and sphin-
golipids function together to carry out a wide variety of
cellular functions. The conclusion that sterols and sphingo-
lipids function together is consistent with one of the tenets of
the raft hypothesis. The other main tenet of the raft hypoth-
esis is that the increased order produced by sterol–sphingo-
lipid interactions is important for function. To begin to test
this, we measured plasma membrane anisotropy as an indi-
cator of membrane order. Even though there were substan-
tial and significant differences in anisotropy, indicating a
decrease in membrane order in several of the mutants, we
were not able to correlate the measurements of membrane
anisotropy with any of the phenotypes we assayed, and
therefore we conclude that membrane order is not likely to
have a great influence on the functions we examined. There-
fore, our results do not provide support for this part of the
raft hypothesis.
The raft hypothesis has been invoked to explain a large
number of membrane trafficking events, which prompted us
to examine the localization of two plasma membrane pro-
teins that have been shown to be localized in microdomains
of the plasma membrane. Here again, the raft hypothesis
does not easily help to explain the results of steady-state
localization of Tat2p and Can1p in the various single and
double mutants. The two transporters colocalize to the same
plasma membrane patches, but they show completely dif-
ferent dependence on sterols and sphingolipids for their
localization. Localization of Tat2p, which was affected by
sphingolipid and sterol mutations, did not correlate with
anisotropy measurements. It could be that anisotropy mea-
surements of the plasma membrane do not reflect fluidity of
the compartment where Tat2p sorting occurs (Golgi or en-
dosomal compartment) or that measuring the overall fluid-
ity of the membrane does not indicate the fluidity in rafts, so
we cannot disprove involvement of liquid order phases. On
the other hand, there is no reason from our studies or others
in the literature at this time to invoke a role for liquid order
phases in vivo.
In what ways could sterol–sphingolipid interactions influ-
ence function with such a complex pattern of phenotypes? A
trivial explanation would be that addition of sterol muta-
tions with sphingolipid mutations cause an indirect effect by
generally increasing the stress to the cells, which affects
many functions. This is not the case for the hypersensitivities
seen here to caffeine or sorbic acid, which do not correlate
with stress gene induction. Indirect effects, although cer-
tainly occurring in some cases, are unlikely to be a common
explanation for the synthetic effects we see because of the
specificity of the position of hydroxylation of the sphingo-
lipid and because different combinations of specific sterol
and sphingolipid mutations affect only specific cellular path-
ways rather than having highly pleiotropic effects.
Biophysical (Ahmed et al., 1997; Radhakrishnan et al.,
2001; Feigenson, 2007) and molecular dynamics (Aittoniemi
et al., 2007) experiments have clearly demonstrated that ste-
rols and sphingolipids can interact preferentially in artificial
membranes. This means that these lipids exist in at least two
forms in the membrane, free sterol and sphingolipid, as well
as sterol–sphingolipid complexes. Our results suggest that
this interaction will also be seen in vivo if suitable tech-
niques become available. We postulate that most of the
phenotypes seen here are mainly the result of defects in
direct protein–lipid interactions and not changes in the flu-
idity properties of the membrane or membrane domains.
Any integral or peripheral membrane protein could interact
with either a sterol, a sphingolipid, or a sphingolipid-sterol
complex, helping to explain the complexity of the pheno-
typic analysis. Membrane proteins might require the sterols
and/sphingolipids for proper folding, assembly, targeting,
regulation, or activity. Eukaryotic membrane proteins have
had a long time to optimize these interactions during evo-
lution because most cells have sterols and all have sphingo-
lipids. Direct sterol–sphingolipid interactions could also
help to explain why it is so difficult to express, purify, and
crystallize eukaryotic membrane proteins in bacteria.
There are various ways to interpret the enhancement of
phenotypes we have seen. For example, in erg4 and sur2
single mutant cells Pdr12p shows substantial activity, but in
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erg4 sur2 double mutants activity is lost. Pdr12p might re-
quire interaction with sterol–sphingolipid complexes for full
activity. The interaction could be reduced because of a stron-
ger change in shape of the complex due to the combination.
The complex might adapt a different tilt in the membrane
because of the two mutations. Molecular dynamics studies
suggest that sphingomyelin binding to cholesterol controls
its tilt in the lipid bilayer (Aittoniemi et al., 2006). Alterna-
tively, the combination of the erg4 and sur2 mutations could
affect the equilibrium between the free lipids with sterol–
sphingolipid complexes affecting Pdr12p activity. We pro-
pose that this paradigm—of protein interaction with sterols,
sphingolipids, or their complexes—could explain the major-
ity of phenotypes we see and that have been shown to
depend upon sterols or sphingolipids in the literature with-
out invoking the need for order in the membranes.
In order for sterols and sphingolipids to function together,
their structural compatibility had to be maintained through
evolution. Strikingly, there was one outlier from the lipid
analysis of the double erg mutants (Figure 2). The sphingo-
lipid pattern in the erg5 erg6 double mutant was more sim-
ilar to wild type than the corresponding single mutants. The
double mutation is “sphingolipid neutral.” The ERG5 and
ERG6 genes are responsible for changes in the sterol side
chain, the principle difference in the biosynthetic pathways
of cholesterol and ergosterol. The two genes are linked in S.
cerevisiae. This suggests that the ERG5 and ERG6 genes could
have been inherited or lost together during evolution with-
out causing major sphingolipid changes, allowing a coevo-
lution of sphingolipids and sterols.
This study also demonstrates that changes in sterol and
sphingolipid composition can affect how a cell responds to a
drug or inhibitor. Several examples are shown here, most
prominently, the hypersensitivity of the erg2 scs7 double
mutant to caffeine and rapamycin. Our data show that the
reduction in activity of TORC2, not TORC1, the direct target
of caffeine and rapamycin, is the reason for the hypersensi-
tivity. The extent to which this paradigm can be extended to
humans is not presently clear, but it is evident that genetic
factors and diet affect sensitivity and effects of certain drugs.
Sterols and sphingolipid composition could play an impor-
tant role in pharmacological variations in the population.
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